Open AccessEfficacy of ulinastatin for the treatment of patients with severe acute pancreatitis
Author(s) -
Jianhui Yao,
Weimin Liu
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000017644
Subject(s) - medicine , cinahl , ulinastatin , psycinfo , cochrane library , medline , adverse effect , intensive care medicine , randomized controlled trial , scopus , acute pancreatitis , data extraction , quality of life (healthcare) , emergency medicine , psychiatry , nursing , political science , psychological intervention , law
Background: The aim of this study is to explore the efficacy and safety of ulinastatin for the treatment of patients with severe acute pancreatitis (SAP). Methods: We will search randomized controlled trials which assess the efficacy and safety of ulinastatin for patients with SAP from the electronic databases of Cochrane Library, MEDILINE, EMBASE, CINAHL, PsycINFO, Scopus, CBM, Wangfang, VIP, and CNKI. All electronic databases will be searched from inception to the present with no limitations of language and publication status. Two researchers will carry out study selection, data extraction, and study quality assessment independently. Another researcher will help to resolve any disagreements between 2 researchers. Results: The outcomes include overall mortality, time of hospital stay, complications of systematic or local infection, multiple organ deficiency syndrome, health related quality of life (as measured as the 36-Item Short Form Health Survey), and adverse events related to nutrition. Conclusion: This study will provide evidence to evaluate the efficacy and safety of ulinastatin in the treatment of patients with SAP. Systematic review registration: PROSPERO CRD42019149566.